ANIX Anixa Biosciences Inc
Company Analysis
Latest News
π’ Anixa Biosciences is trading 6% up in after-hours trading with no confirmed company-specific catalyst
Anixa Biosciences is trading 6.03% up now at $3.69 in after-hours trading after closing at $3.48 on August 28, 2026, with no confirmed company-specific...
π’ Anixa Biosciences is trading 6.1% up in pre-market β no confirmed company-specific catalyst
Anixa Biosciences is trading at $3.82 (+6.11%) after rising before the August 28, 2026 open, with no confirmed company-specific catalyst identified. - Recent...
π΄ Anixa Biosciences is trading 15.27% down in pre-market; cause unclear
Anixa Biosciences is trading 15.27% down now at $3.05 after falling sharply before the August 28, 2026 open; no confirmed company-specific announcement,...
π΄ Anixa Biosciences is trading 16.23% down in pre-market with no confirmed company-specific catalyst
Anixa Biosciences is trading 16.23% down at $3.02, with no confirmed company-specific announcement, filing, earnings release, or clinical update explaining the...
π΄ Anixa Biosciences is trading 7.17% down in after-hours trading with no confirmed company-specific catalyst
Anixa Biosciences is trading 7.17% down now at $3.35 in after-hours trading after closing at $3.60 on August 26, 2026, with no confirmed company-specific...
π’ Anixa Biosciences is trading 5.37% up in pre-market as broader biotechnology strength lifts the sector
Anixa Biosciences is trading 5.37% up at $3.86 as broader biotechnology strength lifts the sector. - XBI gained 2.06% during the August 25 regular session,...
π’ Anixa Biosciences is trading 5.4% up in after-hours trading as XBI gained 2.06%
Anixa Biosciences is trading 5.37% up now at $3.86, as broader biotechnology strength lifted the sector on August 25, 2026. - Biotechnology ETF XBI gained...
π’ Anixa Biosciences is trading 6.35% up today amid broader biotechnology-sector strength
Anixa Biosciences is trading 6.35% up at $3.85, supported primarily by broader biotechnology-sector strength, with XBI up 2.06% during the regular session. -...
π’ Anixa Biosciences is trading 5% up in pre-market amid broader global risk-on sentiment
Anixa Biosciences is trading at $3.78, up 5.22%, amid broader global risk-on sentiment. - U.S. futures point higher; the Nasdaq Composite is up 0.62%. -...
Anixa's Vaccine Data Sparks a 9% Rally, but Can a Zero-Revenue Biotech Sustain the Momentum to Phase 2?
Shares of Anixa Biosciences surged 9.3% to $3.75 on August 19 after the company repackaged its strongest clinical data ahead of a marquee investor conference,...
π’ Anixa Biosciences is trading 9.33% up today after positive breast-cancer vaccine Phase 1 results
Anixa Biosciences is trading 9.33% up at $3.75 after positive breast-cancer vaccine Phase 1 results and encouraging ovarian-cancer CAR-T survival...
π΄ Anixa Biosciences is trading 8.31% down today in pre-market as risk-off sentiment pressures equities
Anixa Biosciences is trading 8.31% down in pre-market at $3.20, amid broader risk-off sentiment. - Closed at $3.49 on August 17, 2026, when it gained 9.75%. -...
π’ Anixa Biosciences is trading 10.06% up today, with no clear catalyst identified
Anixa Biosciences is trading 10.06% up at $3.50, but no clear company-specific catalyst has been identified for August 17, 2026. - CEO Amit Kumarβs purchase...
π’ Anixa Biosciences is trading 5.6% up today β no clear catalyst identified
Anixa Biosciences is trading 5.6% up now at $3.36, with no clear company-specific catalyst identified for August 17, 2026. - Recent coverage references CEO...
π’ Anixa Biosciences is trading 6.46% up in after-hours trading with no definitive catalyst identified
Anixa Biosciences is trading at $3.46 (+6.46%) in after-hours trading, with the move appearing speculative or liquidity-driven and no definitive catalyst...
π΄ Anixa Biosciences is trading 12% down today reversing an unexplained pre-market spike
Anixa Biosciences is trading at $3.00 (12% down) as the stock reverses a sharp, largely unexplained pre-market jump seen on August 03, 2026. β’ The move...
π’ Anixa Biosciences is trading 13.7% up today despite no clear company-specific catalyst
Anixa Biosciences is trading at $3.89 (+13.74%) in pre-market following a sharp overnight move with no fresh company-specific announcements identified. β’ The...
π΄ Anixa Biosciences is trading 6.1% down today amid biotech sector weakness
Anixa Biosciences is trading 6.1% down at $3.34 today, giving back a portion of its recent rebound as the broader biotech sector faces selling pressure. β’ The...
π’ Anixa Biosciences is trading 6.2% up today amid a broader market rebound
Anixa Biosciences is trading 6.2% up at $3.78 in pre-market, appearing to track a broader risk-on sentiment across U.S. equities. β’ The move extends a modest...
π’ Anixa Biosciences up 5.8% as CEO boosts stake and stock rebounds from pullback
β’ Anixa Biosciences' CEO Amit Kumar made recent significant insider purchases, acquiring thousands of shares on July 27 and July 24. β’ The stock is rebounding...